Actavis to Present at the Goldman, Sachs & Co. 34th Annual Global Healthcare Conference 2013

PARSIPPANY, N.J., June 4, 2013 /PRNewswire/ -- Actavis, Inc. (NYSE: ACT), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Actavis’ President and Chief Executive Officer, will provide an overview and update of the Company’s business at the Goldman Sachs 34^th Annual Global Healthcare Conference on Wednesday, June 12, 2013 at 8:00 AM Pacific Time at the Terranea Resort, Rancho Palos Verdes, California. The presentation will be webcast live and can be accessed on Actavis’ Investor Relations Web site at http://ir.actavis.com. The webcast can also be accessed at the following URL:

http://cc.talkpoint.com/gold006/061113a_gm/reports.asp?entity=3_MP7DP11

An archived version will be available approximately one hour after the live presentation ends and can be accessed at the same locations for 90 days.

About Actavis, Inc.
Actavis, Inc. (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. Actavis has global headquarters in Parsippany, New Jersey, USA.

Operating as Actavis Pharma, Actavis develops, manufactures and markets generic, branded generic, legacy brands and Over-the-Counter (OTC) products in more than 60 countries. Actavis Specialty Brands is Actavis’ global branded specialty pharmaceutical business focused in the Urology and Women’s Health therapeutic categories. Actavis Specialty Brands also has a portfolio of five biosimilar products in development in Women’s Health and Oncology. Actavis Global Operations has more than 30 manufacturing and distribution facilities around the world, and includes Anda, Inc., a U.S. pharmaceutical product distributor.

For press release and other company information, visit Actavis’ Web site at http://www.actavis.com.

(Logo: http://photos.prnewswire.com/prnh/20130124/NY47381LOGO)

SOURCE Actavis, Inc.